Open access
Aug 2026
Loss of LATS1 promotes immune evasion in colon cancer via YAP/TEAD-driven lactate metabolism reprogramming
A novel LATS1–LDHA–lactate axis that drives immune evasion in colon cancer through metabolic remodeling is identified, highlighting LATS1 as a potential therapeutic target for enhancing anti-tumor immunity.
Zhe Zhang, Hankun Liu, Yuxuan Li et al.
· Scientific Reports · 0 citations